Malin Corporation reported EUR62.6M in Current Assets for its fiscal semester ending in December of 2024.





Current Assets Change Date
Akebia Therapeutics USD 220.78M 8.77M Sep/2026
Alaunos Therapeutics USD 666K 304K Jun/2026
ALKERMES USD 1.58B 57.83M Sep/2026
Avita Medical AUD 28.39M 7.1M Jun/2026
Dianthus Therapeutics USD 856.04M 41.5M Sep/2026
Eurofins Scientific SE EUR 2.81B 161M Jun/2026
Ionis Pharmaceuticals USD 2.36B 129.77M Sep/2026
IQVIA Holdings USD 6.45B 225M Sep/2026
Lonza CHF 8B 3.41B Dec/2025
Malin Corporation EUR 62.6M 26.7M Dec/2024
Moderna USD 7.34B 1.53B Sep/2026
Organon & Co USD 5.37B 258M Sep/2026
Ovoca Bio EUR 2.07M 510K Dec/2025
Revvity USD 1.86B 436.33M Sep/2026
Tectonic Therapeutic USD 231.1M 8.79M Jun/2026
Viatris USD 10.3B 242.1M Sep/2026
Xeris Pharmaceuticals USD 289.26M 14.51M Sep/2026